Insider Transactions Reported by 9 Insiders of AIM ImmunoTech Inc.

Symbol: AIM on NYSE
Location: Ocala, FL

Quick Takeaways

AIM - AIM ImmunoTech Inc. has 9 insiders with reported activity on this page.
No net insider buy/sell flow is currently reported for the last year.
Recent transaction rows are available for direct filing-level review.

What Changed

No meaningful buy/sell imbalance is currently visible in the one-year window.
Activity will update as new Forms 3/4/5 are filed.

Why This Matters

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Source Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 16 Apr 2025.

Buys

Shares: 0

Insiders: 0

Sells

Shares: 0

Insiders: 0

Net

Shares: 0

Insiders: 0

Window (months)	Buy $	Sell $	Net $
0-3	$0	$0	$0
3-6	$0	$0	$0
6-9	$0	$0	$0
9-12	$0	$0	$0

AIM ImmunoTech Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Valuation	Report Date
Stewart Appelrouth	Director	$76,968	Mixed	31 Dec 2024
Thomas K. Equels	CEO & President, Director	$50,498	Mixed	16 Mar 2026
Peter W. Rodino III	COO, Secretary, Gen. Counsel	$34,953	Filing P/S	04 Apr 2025
Nancy Bryan	Director	$33,858	Mixed	14 Mar 2025
David I. Chemerow	Director	$22,468	Mixed	16 Mar 2026
William M. Mitchell	Director	$13,297	Mixed	21 Apr 2025
Ted D. Kellner	Director	$2,603	Mixed	17 Jul 2025
Ellen M. Lintal	Former Chief Financial Officer		Mixed	04 Apr 2022
Robert Dickey IV	Chief Financial Officer		Mixed	04 Apr 2022

Top shareholders of AIM ImmunoTech Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ARMISTICE CAPITAL, LLC	13D/G	—	5%	3,349,740	$200,984	$0	31 Dec 2024	13D/G
Todd Deutsch	13D/G	—	2.7%	1,716,100	$102,966	$0	19 Dec 2024	13D/G
DRW Securities, LLC	13F	Company	— class O/S missing	69,545	$78,585	—	31 Dec 2025	13F
Stewart Appelrouth	3/4/5	Director	— class O/S missing	388,729	$76,968	—	31 Dec 2024	3/4/5
Thomas K. Equels	3/4/5	CEO & President, Director	— mixed-class rows	113,922 mixed-class rows	$50,498	—	16 Mar 2026	3/4/5
Peter W. Rodino III	3/4/5	COO, Secretary, Gen. Counsel	— class O/S missing	401,762	$34,953	—	04 Apr 2025	3/4/5
Nancy Bryan	3/4/5	Director	— class O/S missing	291,882	$33,858	—	14 Mar 2025	3/4/5
David I. Chemerow	3/4/5	Director	— mixed-class rows	78,466 mixed-class rows	$22,468	—	16 Mar 2026	3/4/5
VANGUARD GROUP INC	13F	Company	— class O/S missing	17,502	$19,777	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	17,376	$19,634	—	31 Dec 2025	13F
William M. Mitchell	3/4/5	Director	0.78%	522,103	$13,297	—	21 Apr 2025	3/4/5
Ted D. Kellner	3/4/5	Director	0.06%	37,205	$2,603	—	17 Jul 2025	3/4/5
MORGAN STANLEY	13F	Company	— class O/S missing	864	$976	—	31 Dec 2025	13F
UBS Group AG	13F	Company	— class O/S missing	379	$428	—	31 Dec 2025	13F
Community Bank, N.A.	13F	Company	— class O/S missing	132	$147	—	31 Dec 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	125	$141	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	28	$32	—	31 Dec 2025	13F
OSAIC HOLDINGS, INC.	13F	Company	— class O/S missing	15	$16	—	31 Dec 2025	13F
HOEY INVESTMENTS, INC	13F	Company	— class O/S missing	10	$12	—	31 Dec 2025	13F
Steward Partners Investment Advisory, LLC	13F	Company	— class O/S missing	2	$2	—	31 Dec 2025	13F
Farther Finance Advisors, LLC	13F	Company	— class O/S missing	1	$1	—	31 Dec 2025	13F
Intesa Sanpaolo Wealth Management	13F	Company	— class O/S missing	1	$1	—	31 Dec 2025	13F
Ellen M. Lintal	3/4/5	Former Chief Financial Officer	— class O/S missing	50,000	—	—	04 Apr 2022	3/4/5

Recent Insider Transactions by Companies or Individuals for AIM ImmunoTech Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Shares	Shares Owned	Date	Ownership
Thomas K. Equels	AIM	Common stock	Conversion of derivative security	64.2%	25,000	63,922	12 Mar 2026	Direct
Thomas K. Equels	AIM	Series G Convertible Preferred Stock	Conversion of derivative security	-100%	-25	0	12 Mar 2026	Direct
David I. Chemerow	AIM	Common Stock	Conversion of derivative security	726.5%	25,000	28,441	12 Mar 2026	Direct
David I. Chemerow	AIM	Series G Convertible Prefered Stock	Conversion of derivative security	-100%	-25	0	12 Mar 2026	Direct
Thomas K. Equels	AIM	Class G Warrants	Other		50,000	50,000	06 Mar 2026	Direct
Thomas K. Equels	AIM	Series G Convertible Preferred Stock	Other		25	25	06 Mar 2026	Direct
David I. Chemerow	AIM	Class G Warrants	Other		50,000	50,000	06 Mar 2026	Direct
David I. Chemerow	AIM	Series G Convertible Preferred Stock	Other		25	25	06 Mar 2026	Direct
David I. Chemerow	AIM	Common Stock	Award	436.8%	2,800	3,441	05 Feb 2026	The David I Chemerow 1992 Trust
Thomas K. Equels	AIMI	Common Stock	Purchase	0.28%	107	38,885	13 Jun 2025	Direct
Thomas K. Equels	AIMI	Common Stock	Purchase	0.27%	103	38,675	12 Jun 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.